Similarly to our findings, no significant differences in ghrelin levels were found among patients with established RA receiving traditional DMARDs treatment (17, 18) neither in patients under anti-TNF-α therapy (39) when compared to healthy controls. Here, TNF is linked to rheumatoid arthritis.